AviaraDx’s diagnostic tests can be used in the molecular classification of cancers and to assist oncologists in making therapeutic decisions.
Aviara CancerType ID provides improved cancer classification, especially for patients diagnosed with metastatic cancer where the origin is uncertain or unknown.
Aviara Breast Cancer Index offers a combined assessment of two Aviara markers (H/l and MGI) for risk prognosis and treatment response prediction for chemo- and hormonal therapy.
Phone: 1800 333 421
Lonza 4D-Nucleofector LV Unit PRO electroporation unit
Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...
Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)
The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...
Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms
The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...
